Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Aakaar Medical Technologies Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Aakaar Medical Technologies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aakaar Medical Tech - Price movement

    23 Jul 2025, 6:40PM Significant movement in price has been observed in Aakaar Medical Technologies Limited. The Exchange, in order to ensure that investors have latest re
  • Aakaar Medical Tech - Updates

    23 Jul 2025, 3:10PM Aakaar Medical Technologies Limited has informed the Exchange regarding 'Price Movement'.
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Jul 2025, 5:43PM Aakaar Medical Technologies Limited has informed the Exchange about Outcome
  • Aakaar Medical Tech - Price movement

    22 Jul 2025, 5:19PM Significant movement in price has been observed in Aakaar Medical Technologies Limited. The Exchange, in order to ensure that investors have latest re
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Jul 2025, 4:09PM Aakaar Medical Technologies Limited has informed the Exchange about Outcome
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Jul 2025, 4:44PM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    15 Jul 2025, 4:32PM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of Investor Meet
  • Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    11 Jul 2025, 3:18PM Aakaar Medical Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aakaar Medical Tech has submitted to BSE the Shareholding Pattern for the Period Ended June 26, 2025

    4 Jul 2025, 4:10PM As of June 2025, 67.01% is owned by Promoters and 32.99% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 63.01% and Forei
  • Aakaar Medical Technologies Ltd. debuts with 4.16% premium at Rs 75.00

    27 Jun 2025, 11:00AM Aakaar Medical Technologies Ltd. makes a strong debut on the bourses with scrip got listed at Rs 75.00 on the Bombay Stock Exchange, a 4.16 per cent p
  • Aakaar Medical Tech announces launch of initial public offering

    17 Jun 2025, 3:50PM Aakaar Medical Technologies Ltd. has announced public offering of 3752000 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 62.00 per sha

Key fundamentals

Evaluate the intrinsic value of Aakaar Medical Technologies Ltd stock 

Name March-25 March-24
Assets 45.9411 27.5982
Liabilities 45.9411 27.5982
Equity 10.4224 0.7
Gross Profit 9.7369 4.9989
Net Profit 6.0395 2.8702
Cash From Operating Activities -5.4063 -8.0441
NPM(%) 9.8 6.22
Revenue 61.5828 46.111
Expenses 51.8459 41.1121
ROE(%) 22.4 10.64

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aakaar Medical Technologies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 878.25 -1.44 29.14 0.00 301.39 0.57
Lotus Eye Hospital and Institute Ltd 72.49 -1.28 207.11 0.00 3.55 0.00
Vaishali Pharma Ltd 12.70 2.92 211.67 0.00 3.13 0.00
Astec Lifesciences Ltd 879.50 -2.96 0.00 0.00 -601.21 0.00

Company Info

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Read More

Parent Organisation

Aakaar Medical Technologies Ltd.

Founded

20/06/2013

Managing Director

Mr.Rahul Babasaheb Sawakhande

NSE Symbol

AAKAARSM

FAQ

The current price of Aakaar Medical Technologies Ltd is

The 52-week high for Aakaar Medical Technologies Ltd is

The market capitalization of Aakaar Medical Technologies Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aakaar Medical Technologies Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aakaar Medical Technologies Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aakaar Medical Technologies Ltd shares.

The CEO of Aakaar Medical Technologies Ltd is Mr.Rahul Babasaheb Sawakhande, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT